Patty Maysent, MPH, MBA, has been appointed interim Chief Executive Officer of UC San Diego Health, bringing to the role more than 25 years of exceptional executive experience in hospital leadership and health services management.
The National Science Foundation (NSF) has awarded the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, a one-year extension to continue operating its Gordon supercomputer, providing continued access to the cluster for a wide range of researchers with data-intensive projects.
An international team of scientists headed by biologists at UC San Diego has discovered that an important class of stem cells known as human “induced pluripotent stem cells,” or iPSCs, which are derived from an individual’s own cells, can be differentiated into various types of functional cells with different fates of immune rejection.
The Clinical and Translational Research Institute (CTRI) at University of California, San Diego has received a five-year Clinical and Translational Science Award (CTSA) for approximately $52 million from the National Center for Advancing Translational Science, part of the National Institutes of Health.
UC San Diego is ranked the 14th best university in the world for the third consecutive year, according to the 2015 Academic Ranking of World Universities (ARWU). The rankings were recently released by the Center for World-Class Universities at Shanghai Jiao Tong University, a public research university located in Shanghai, China, renowned as one of the oldest and most prestigious and selective universities in China. In addition, UC San Diego’s programs in life sciences, engineering, computer science, chemistry, and economics are ranked among the top 20 in the world. Nationally, UC San Diego is listed as the 12th best university.
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest that the primary effect of varenicline has been to displace the use of older tobacco addiction therapies, such as nicotine patches and the antidepressant, bupropion.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
